1Jemal A ,Siegel R,Ward E,et al. Cancer statistics[ J]. CA Cancer J Clin, 2008 ;58(2) :71-96.
2Couzinet B, Meduri G, Lecce MG ,et al. The post menopausal ovary is not a major androgen production gland[J]. Clin Endocfinol Metab ,2001 ;86: 5066-6.
3Femand L, Van L, Claude L, et al. Endocrine and intraerine sources of androgens in women : inhibition of breast cancer and other roles of andro- gens and their precursor dehydroepi androsterone [J].Endocrine Rev, 2003 ;24(2) : 152-82.
4Sasano H, Suzuki T, Miki Y, et al. Intracriuology of estrogens and andro- gens in breast carcinoma[J]. Steroid Biochem Mol Biol,2008 ; 108 ( 3- 5) :181-5.
5Lonning P, Helle S, Johannessen D, et al. Relations between sex hor- mones,sex hormone binding globulin, insulin-like growth factor binding protein-1 in postmenopausal breast eancer patients[J]. Clin Endocrinol ( Oxf), 1995 ;42( 1 ) :23-30.
6Honing M, Hirschberg A, Skoog L, et al. Testosterone inhibits estrogen/ progestogen-lnducecl breast cell proliferation in postmenopausal women [ J ]. Menopause,2007 ; 14 (2) : 183-90.
7Kaaks R, Rinaldi S, Key TJ, et al. Postmenopausal serum androgens, oes- trogens and breast cancer risk : the European prospective investigation into cancer and nutrition[J].Endocrine-Related Cancer,2005 ; 12 (4) : 1071- 82.
8Catherine S, Deirdre H, Susan R, et al. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hy-perplasia in postmenopausal women[J].Cancer Epidemiol Biomarkers Prey, 2005 ;4 (7) : 1660-5.
9Mason B,Holdaway I,Skinner S,et al. The relationship of urinary and plasma androgens to stefiod receptors and menopausal status in breast cancer patients and their influence on survival [J]. Breast Cancer Res Treat, 1994 ;32 (2) :203-12.
10Berrino F, Pasanisi P, Bellati C, et al. Serum testosterone levels and breast cancer recurrence [ J 1. Int J Cancer, 2005 ; 113 ( 3 ) :499 -502.
2Travis RC, Key TJ. Estrogen exposure and breast cancer risk [ J ]. Breast Cancer Res, 2003,5 (5) : 239 - 247.
3Simpson ER. Sources of estrogen and their importance[ J ]. J Steroid Biochem Mol Biol,2003,86( 3 - 5 ) :225 - 230.
4Maecib A, Madeddu C, Gramignano G, et al. Correlation of body mass index and leptin with tumor size and stage of dis- ease in hormone - dependent postmenopansal breast cancer: preliminary results and therapeutic implications [ J ]. J Mol Med (Berl) ,2010,88 (7) :677 - 686.
5Key TJ, Appleby P, Barnes I, et al. Endogenous sex hor- mones and breast caneer in postmenopausal women: reanal- ysis of nine prospective studies [ J ]. J Natl Cancer Inst, 2002,94(8) :606 -616.
6Key TJ,Appleby PN, Reeves GK, et al. Circulating sex hor- mones and breast cancer risk factors in postmenopausal women: Reanalysis of 13 studies [ J ]. Br J Cancer,2011,105 (5) :709 -722.
7Woolcott CG, Shvetsov YB, Stanczyk FZ, et al. Plasma sex hormone concentrations and breast cancer risk in an ethni- caUy diverse population of postmenopausal women: The Mul- tiethnic Cohort Study [ J ]. Endocr Relat Cancer, 2010, 17 (1) :125 -134.
8Santen R J, Allred DC, Ardoin SP, et 'M. Postmenopausal hor- mone therapy: an Endocrine Society scientific statement [ J ]. J Clin Endocrinol Metab ,2010 ,95 (7) : S1 - S66.
9Verkasalo PK, Thomas HV, Appleby PN, et al. Circulating levels of sex hormones and their relation to risk factors for breast cancer:a cross- sectional study in 1092 pre- and post menopausal women ( United Kingdom) [ J ]. Cancer Causes Control,2001,12 ( 1 ) :47 - 59.
10Missmer SA, Eliassen ACH, Barbieri RL, et al. Endogenous estrogen, androgen, and progesterone concentrations andbreast cancer risk among postmenopausal women [ J ]. J Natl Cancer,2004,96(24) : 1856 - 1865.
